Indivior Pharmaceuticals INDV
NASDAQ INDV
$35.71 +0.33 (+0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Price to Sales (2024 - 2026)

Updated

Indivior Pharmaceuticals' Price to Sales was 3.64 in Q2 2026, up 132.1% from 1.57 a year earlier and up 26.3% from the prior quarter.

Analysis

Indivior Pharmaceuticals (INDV) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Indivior Pharmaceuticals came in at 3.62, up 177.7% from FY2024.

  • In earlier years, Price to Sales was 1.30 in FY2024 (-31.6%), 1.91 in FY2023 (-42.1%), 3.29 in FY2022 (+3.7%) and 3.18 in FY2021.
  • Compared with a year earlier, Price to Sales has increased for three straight quarters.
  • Per Business Quant data, INDV's Price to Sales in the three quarters before Q2 2026 was 2.88 (Q1 2026), 3.62 (Q4 2025) and 2.55 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Indivior Pharmaceuticals 4.18 Bn 3.14 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.64
Mar 31, 2026 2.88
Dec 31, 2025 3.62
Sep 30, 2025 2.55
Jun 30, 2025 1.57
Mar 31, 2025 1.02
Dec 31, 2024 1.30
API Access

Indivior Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=INDV&period=max&api_key=YOUR_API_KEY